Immunological analysis of pulmonary hypertension in connective tissue diseases

Journal of Rheumatology

Volumn 26, Issue 11, 1999, Pages 2357-2362

  Nishimaki, Tomoe ^a   Aotsuka, Shinichi ^b   Kondo, Hirofumi ^b   Yamamoto, Kazuhiko ^b   Takasaki, Yoshinari ^b   Sumiya, Morito ^b   Yokohari, Ryuichi ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Anti cardiolipin; Anti endothelial cell; Anti U1RNP; Mixed connective tissue disease; Pulmonary hypertension

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERTENSION; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; CARDIOLIPINS; CONNECTIVE TISSUE DISEASES; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

EID: 0032730979     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen. Am J Med 1972;52:148-59.
2. Reichlin M. Problems in differentiation of SLE and mixed connective tissue disease. N Engl J Med 1976;21:1194-5.
3. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: subsequent evaluation of the 25 original patients. Medicine 1980;59:239-48.
4. Hoffman R, Sharp GC. Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct? J Rheumatol 1995;22:586-9.
5. Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981;124:499-503.
6. Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984;63:92-107.
7. Hosoda Y, Suzuki Y, Takano M, et al. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol 1987;14:826-30.
8. Kasukawa R, Kida S, Nishimaki T, et al. Clinical features and causes of death in 39 patients with MCTD. Annual report of the research committee for mixed connective tissue disease of the Ministry of Health and Welfare of Japan. 1986;24-32.
9. Quismorio FP Jr, Sharma O, Koss M, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984;13:349-59.
10. Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1986;64:998-1004.
11. Kasukawa R, Nishimaki T, Takagi T, et al. Pulmonary hypertension in connective tissue disease: clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 1990;9:56-62.
12. Sharp GC. Anti-nRNP and anti-Sm antibodies. Arthritis Rheum 1982;25:757-60.
13. Kahaleh MB, Osborn I, Leroy EC. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and Raynaud's phenomenon. Ann Intern Med 1981;94:482-4.
14. Okawa-Takatsuji M, Aotsuka S, Uwatoko S, et al. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease. Clin Exp Immunol 1994;98:427-33.
15. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and anti-nuclear antibodies. International Congress Series 719. Amsterdam: Excerpta Medica; 1987:41-7.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Nishimaki T, Aotsuka S, Kunieda T, Yokohari R. Preliminary criteria for the diagnosis of pulmonary hypertension in mixed connective tissue disease [abstract in English]. Ryumachi 1991;31:159-66.
20. Okubo M, Yamamoto K, Kato T, et al. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein: a protein in autoimmune disease patients. J Immunol 1993;151:1108-15.
21. Maina CV, Riggs PD, Grandea AG III, et al. A vector to express and purify foreign proteins in Escherichia coli by fusion to, and separation from, maltose binding protein. Gene 1988;74:365-73.
22. Masuyama J, Minato N, Kano S. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. J Clin Invest 1986;77:1596-605.
23. Yamamoto K, Misaki Y, Mato T, et al. Establishment of quantitative ELISA with recombinant nRNP antigens and analyses of the cross-reactive epitopes of the antigens. Annual report of the research committee for mixed connective tissue disease of the Ministry of Health and Welfare of Japan. 1991:45-7.
24. Rosenbaum J, Pottinger BE, Woo P, et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6.
25. Matsuura E, Igarashi Y, Fujimoto M. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177-8.
26. Kida S. Studies on von Willebrand factor antigen in endothelial cells and sera of patients with connective tissue diseases. Jap J Rheumatol 1992;4:21-32.
27. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells: macrophage dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 1986;141:1529-35.
28. Asherson RA, Higenbottam TW, Dinh Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990;17:1292-8.
29. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1989;68:353-65.
30. Graziano FM, Friedman LC, Grossman J. Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathologic findings, and review of literature. Clin Exp Rheumatol 1983;1:251-5.
31. Alarcon-Segovia D, Cardiel MH, Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol 1989;16:762-7.
32. Harris EN, Gharavi AE, Loizou S, et al. Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985;16:1-6.
33. Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971;9:753-60.
34. Tan EM, Pearson CM. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 1972;9:753-60.
35. Hashemi S, Smith CD, Izaquirre CA. Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J Lab Clin Med 1987;109:434-40.
36. Yoshio T, Masuyama J, Sumiya M, et al. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21:2058-63.
37. Vismara A, Meroni PL, Tincani A, et al. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988;74:247-53.
38. Hasselaar P, Derksen RHWM, Blokzijil L, de Groot PG. Crossreactivities of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 1990;63:169-73.
39. Kaise S, Watanabe H, Kasukawa R. Crossreactivity of anti-cardiolipin antibodies with glycolipids and endothelial cells. Fukushima J Med Sci 1994;40:25-37.
40. D'Cruz DP, Houssiau FA, Ramirez G, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potent marker for nephritis and vasculitis. Clin Exp Immunol 1991;85:254-61.